Femasys (FEMY) Cash from Financing Activities (2020 - 2026)
Femasys posted quarterly Cash from Financing Activities of $342334.0 for Q1 2026, down 93.45% year-on-year from $5.2 million in Q1 2025, and down 96.23% on a QoQ basis from $9.1 million in Q4 2025.
Femasys (FEMY) has 7 years of Cash from Financing Activities data on file, last reported at $342334.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 93.45% year-over-year to $342334.0; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (up 212.48% YoY), and the FY2025 full-year result was $25.1 million, up 1139.74% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $342334.0, down from $9.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $16.1 million in Q4 2023 and bottomed at -$362039.0 in Q3 2022.
- The 5-year median for Cash from Financing Activities is $824252.0 (2023), against an average of $2.9 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities plunged 100.32%; it then surged 19751.64% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$81950.0 in 2022, then soared by 19751.64% to $16.1 million in 2023, then plunged by 93.63% to $1.0 million in 2024, then soared by 785.15% to $9.1 million in 2025, then tumbled by 96.23% to $342334.0 in 2026.
- The last three Cash from Financing Activities figures came in at $342334.0 (Q1 2026), $9.1 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -255.24 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -308.70 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -50.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -147.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -48.13 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -11.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -230.34 Mn |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | 342,334.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 342,334.00 |
| Mar 31, 2026 | 342,334.00 |
| Dec 31, 2025 | 9.08 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 6.98 Mn |
| Sep 30, 2025 | 6.98 Mn |
| Jun 30, 2025 | 3.85 Mn |
| Jun 30, 2025 | 3.85 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Jun 30, 2024 | 223,549.00 |
| Jun 30, 2024 | 223,549.00 |
| Mar 31, 2024 | 778,175.00 |
| Mar 31, 2024 | 778,175.00 |
| Dec 31, 2023 | 16.10 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 870,329.00 |
| Sep 30, 2023 | 870,329.00 |
| Jun 30, 2023 | 3.35 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | -144,060.00 |
| Mar 31, 2023 | -144,060.00 |
| Dec 31, 2022 | -81,950.00 |
| Dec 31, 2022 | -81,950.00 |
| Sep 30, 2022 | -362,039.00 |
| Sep 30, 2022 | -362,039.00 |
| Jun 30, 2022 | -96,650.00 |
| Jun 30, 2022 | -96,650.00 |
| Mar 31, 2022 | -141,006.00 |
| Mar 31, 2022 | -141,006.00 |
| Dec 31, 2021 | -130,755.00 |
| Dec 31, 2021 | -130,755.00 |
| Sep 30, 2021 | -601,324.00 |
| Sep 30, 2021 | -601,324.00 |
| Jun 30, 2021 | 30.58 Mn |
| Jun 30, 2021 | 30.58 Mn |
| Mar 31, 2021 | -144,991.00 |
| Mar 31, 2021 | -144,991.00 |
| Dec 31, 2020 | 7,575.00 |
| Dec 31, 2020 | 7,575.00 |
| Sep 30, 2020 | -2,026.00 |
| Sep 30, 2020 | -2,026.00 |